Cardiac complications in the intensive care unit.

Clinics in chest medicine ·Vol. 20 ·No. 2 ·1999-06-00 ·Pages 269-85

Francis GS

Abstract

Advances in the care of critically ill patients has been startling, especially in patients with acute coronary syndromes. With new therapies and procedures, however, have come new complications. On balance, our patients are better off, but the stakes are now higher and the complications more serious. The need for constant vigilance has never been greater.

MeSH Terms

Adult Aged Anti-Arrhythmia Agents/adverse effects Cardiovascular Diseases/epidemiology,etiology,therapy Cisapride/adverse effects Electrocardiography Erythromycin/adverse effects Female Haloperidol/adverse effects Histamine H1 Antagonists/adverse effects Humans Incidence Intensive Care Units/statistics & numerical data Male Middle Aged Risk Assessment Survival Rate Thrombolytic Therapy/adverse effects United States/epidemiology Water-Electrolyte Imbalance/complications

Chemicals

Anti-Arrhythmia Agents Histamine H1 Antagonists Erythromycin Haloperidol Cisapride

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Francis G S

George M. and Linda H. Kaufman Center for Heart Failure, Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.

Article Info

Journal

Clinics in chest medicine

Abbr.

Clin Chest Med

ISSN

0272-5231

DOI

10.1016/s0272-5231(05)70141-6

Published

1999-06-00

Pages

269-85

Language

English

Region

United States

NLM ID

7907612

Subset

External Links

PubMed source DOI: 10.1016/s0272-5231(05)70141-6 View journal details

Analysis Services

Cardiac complications in the intensive care unit.

Contact

WeChat Official Account